Modulation of immune system inhibitory checkpoints in colorectal cancer
Published
Journal Article
T cell infiltration of colorectal cancer is associated with improved clinical outcome, underlining the importance of the immune system in cancer control; however, immune checkpoints, including the inhibitory T cell molecules CTLA-4 and PD-1 that temper the native immune response, mitigating autoimmunity, are coopted by tumors to facilitate escape from immune surveillance. Blockade of CTLA-4 and PD-1 and its ligand PD-L1, expressed by many tumors, have shown impressive activity in melanoma, renal cell carcinoma, and lung cancer. Immune checkpoint inhibition has been less well studied in colorectal cancer, but preclinical and clinical investigations are in progress. © Springer Science+Business Media New York 2013.
Full Text
Duke Authors
Cited Authors
- Patel, SP; Osada, T; Osada, K; Hurwitz, H; Lyerly, HK; Morse, MA
Published Date
- December 1, 2013
Published In
Volume / Issue
- 9 / 4
Start / End Page
- 391 - 397
Electronic International Standard Serial Number (EISSN)
- 1556-3804
International Standard Serial Number (ISSN)
- 1556-3790
Digital Object Identifier (DOI)
- 10.1007/s11888-013-0184-3
Citation Source
- Scopus